Lung cancer in Teesside (UK) and Varese (Italy): a comparison of management and survival
Open Access
- 1 March 2006
- Vol. 61 (3) , 232-239
- https://doi.org/10.1136/thx.2005.040477
Abstract
Background: The survival of lung cancer patients in the UK is lower than in other similar European countries. The reasons for this are unclear. Methods: Two areas were selected with a similar incidence of lung cancer: Teesside in Northern England and Varese in Northern Italy. Data were collected prospectively on all new cases of lung cancer diagnosed in the year 2000. Comparisons were made of basic demographic characteristics, management, and survival. Results: There were 268 cases of lung cancer in Teesside and 243 in Varese. Patients in Teesside were older (pv 24%; pv 25%; pv 14%; pConclusions: Patients with lung cancer in Teesside presented at a later stage, with more aggressive types of tumour, and had higher co-morbidity than patients in Varese. As a result, the resection rate was significantly lower and survival was worse.Keywords
This publication has 24 references indexed in Scilit:
- CT Screening for Lung Cancer: Past and Ongoing StudiesSeminars in Thoracic and Cardiovascular Surgery, 2005
- The changing epidemiology of lung cancer in EuropeLung Cancer, 2003
- Lung cancer: district active treatment rates affect survivalJournal of Epidemiology and Community Health, 2002
- Management and survival of patients with lung cancer in Scotland diagnosed in 1995: results of a national population based studyThorax, 2001
- Guidelines on the selection of patients with lung cancer for surgeryThorax, 2001
- Resection rates in lung cancerThorax, 1999
- Variation in survival of patients with lung cancer in Europe, 1985–1989European Journal Of Cancer, 1998
- Deprivation and emergency admissions for cancers of colorectum, lung, and breast in south east England: ecological studyBMJ, 1998
- Changes in lung cancer histological types in Varese cancer registry, Italy 1976–1992European Journal Of Cancer, 1997
- Resection rates and postoperative mortality in 7,899 patients with lung cancerEuropean Respiratory Journal, 1996